These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6235869

  • 1. Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studies.
    Lauria F, Raspadori D, Tura S.
    Blood; 1984 Sep; 64(3):667-71. PubMed ID: 6235869
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies.
    Davis S.
    Blood; 1981 Nov; 58(5):1053-5. PubMed ID: 6975137
    [Abstract] [Full Text] [Related]

  • 3. Immunoregulation of B lymphocyte colony formation by T cell subsets in patients with chronic lymphocytic leukemia.
    Fernandez LA, MacSween JM, Langley GR.
    Blood; 1986 Feb; 67(2):294-8. PubMed ID: 2935205
    [Abstract] [Full Text] [Related]

  • 4. T-cell functional abnormality in B-chronic lymphocytic leukaemia: evidence of a defect of the T-helper subset.
    Lauria F, Foa R, Mantovani V, Fierro MT, Catovsky D, Tura S.
    Br J Haematol; 1983 Jun; 54(2):277-83. PubMed ID: 6221752
    [Abstract] [Full Text] [Related]

  • 5. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G.
    Veroff Pathol; 1975 Jun; (0):1-99. PubMed ID: 49138
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population.
    Foa R, Giovarelli M, Jemma C, Fierro MT, Lusso P, Ferrando ML, Lauria F, Forni G.
    Blood; 1985 Sep; 66(3):614-9. PubMed ID: 2992637
    [Abstract] [Full Text] [Related]

  • 7. The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.
    Johnstone AP, Millard RE, Hudson L.
    Clin Exp Immunol; 1982 Mar; 47(3):689-96. PubMed ID: 6979444
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-2 and serum thymic factor enable autologous rosette-forming T lymphocytes to generate helper and cytotoxic functions.
    Sugawara I, Palacios R.
    Scand J Immunol; 1982 Feb; 15(2):233-8. PubMed ID: 6980447
    [Abstract] [Full Text] [Related]

  • 9. Reduced T lymphocyte colonies in B chronic lymphocytic leukaemia. III. Evidence of a proliferative abnormality of the T helper cell population.
    Foa R, Lauria F.
    Clin Exp Immunol; 1982 Nov; 50(2):336-40. PubMed ID: 6217934
    [Abstract] [Full Text] [Related]

  • 10. Normal helper T-cell function in hairy-cell leukaemia.
    Foa R, Lauria F, Raspadori D, Lusso P, Ferrando ML, Fierro MT, Giubellino MC, Catovsky D.
    Scand J Haematol; 1983 Oct; 31(4):322-8. PubMed ID: 6226086
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin secretory function of B cells from untreated patients with chronic lymphocytic leukemia and hypogammaglobulinemia: role of T cells.
    Fernandez LA, MacSween JM, Langley GR.
    Blood; 1983 Oct; 62(4):767-74. PubMed ID: 6224523
    [Abstract] [Full Text] [Related]

  • 12. Impaired T-cell transformation in chronic lymphocytic leukemia (CLL): Demonstration of a blastogenesis inhibitory factor.
    Utsinger PD.
    Blood; 1975 Dec; 46(6):883-90. PubMed ID: 1081891
    [Abstract] [Full Text] [Related]

  • 13. Functional and multimarker analysis of T-cell chronic lymphocytic leukaemia.
    Baldini L, Di Padova F, Cortelezzi A, Neri A, Nobili L, Lavezzi AM, Maiolo AT, Polli EE.
    Scand J Haematol; 1985 Jan; 34(1):88-96. PubMed ID: 3155872
    [Abstract] [Full Text] [Related]

  • 14. Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.
    Velardi A, Prchal JT, Prasthofer EF, Grossi CE.
    Blood; 1985 Jan; 65(1):149-55. PubMed ID: 3155487
    [Abstract] [Full Text] [Related]

  • 15. Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity.
    Chudwin DS, Cowan MJ, Wara DW, Ammann AJ.
    Clin Immunol Immunopathol; 1983 Jan; 26(1):126-36. PubMed ID: 6223739
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte response to pokeweed mitogen in chronic lymphocytic leukemia.
    Lamberson HV, Davey FR, Schreck CM, Zamkoff K, Kurec AS.
    Cancer; 1984 Jun 01; 53(11):2481-6. PubMed ID: 6608985
    [Abstract] [Full Text] [Related]

  • 17. The effect of sera from chronic lymphocytic leukemia patients on normal mitogen-stimulated lymphocytes. A possible correlation with the patients' T and B lymphocytes.
    Komlos L, Halbrecht I, Shachor J, Djaldetti M.
    Exp Hematol; 1978 Aug 01; 6(7):595-600. PubMed ID: 308462
    [Abstract] [Full Text] [Related]

  • 18. Defective T cell-mediated, isotype-specific immunoglobulin regulation in B cell chronic lymphocytic leukemia.
    Moore JS, Prystowsky MB, Hoover RG, Besa EC, Nowell PC.
    Blood; 1988 Apr 01; 71(4):1012-20. PubMed ID: 2895674
    [Abstract] [Full Text] [Related]

  • 19. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
    Isaković K, Lenert G.
    Blood Cells; 1987 Apr 01; 12(2):355-64. PubMed ID: 3497681
    [Abstract] [Full Text] [Related]

  • 20. T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosis.
    Witzig TE, Phyliky RL, Li CY, Homburger HA, Dewald GW, Handwerger BS.
    Am J Hematol; 1986 Feb 01; 21(2):139-55. PubMed ID: 2934974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.